Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants (PREMA)
|ClinicalTrials.gov Identifier: NCT00833222|
Recruitment Status : Completed
First Posted : February 2, 2009
Last Update Posted : December 26, 2017
|Condition or disease|
- To assess the feasibility of measuring body fat deposition by ADP in medically stable late gestation (32-35 weeks), premature infants during a period of rapid postnatal growth.
- To test the relationship between %BF by ADP to %BF by DXA, as well as characterize the relationship between these fat measures with bone measures by quantitative ultrasound and serum levels of insulin, IGF-1, IGF binding proteins, adiponectin and leptin.
- To perform inter- and intra-rater testing of anthropometric, ultrasound, and ADP measurements.
- Compare growth, body composition and bone strength between infants born preterm to infants born full term.
|Study Type :||Observational|
|Actual Enrollment :||72 participants|
|Official Title:||Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||June 2012|
|Actual Study Completion Date :||June 2012|
Full Term Infants
Infants born between 37 4/7 weeks and 42 3/7 weeks gestation.
Infants born between 32 4/7 weeks and 35 3/7 weeks gestation.
- Growth trajectory [ Time Frame: Weekly ]
Biospecimen Retention: Samples With DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00833222
|United States, Utah|
|University of Utah|
|Salt Lake City, Utah, United States, 84132|
|Principal Investigator:||Laurie Moyer-Mileur, PhD||University of Utah|
|Principal Investigator:||Kristine Jordan, MPH, PhD||University of Utah|